WL Gore & Associates has affirmed that the clinical study assessing its Gore Helex implant, designed to close patent foramen ovales (PFOs), was "on track" to meet its estimated completion date in five years' time. The firm made the statement in response to the failure of ...
Please Login to read the full article.
